These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
332 related items for PubMed ID: 29331568
1. Overall survival and oncological outcomes after partial nephrectomy and radical nephrectomy for cT2a renal tumors: A collaborative international study from the French kidney cancer research network UroCCR. Reix B, Bernhard JC, Patard JJ, Bigot P, Villers A, Suer E, Vuong NS, Verhoest G, Alimi Q, Beauval JB, Benoit T, Nouhaud FX, Lenormand C, Hamidi N, Cai J, Eto M, Larre S, El Bakhri A, Ploussard G, Hung A, Koutlidis N, Schneider A, Carrouget J, Droupy S, Marchal S, Doerfler A, Seddik S, Matsugasumi T, Orsoni X, Descazeaud A, Pfister C, Bensalah K, Soulie M, Gill I, Flamand V, Kidney Cancer group of the CCAFUParis, France.. Prog Urol; 2018 Mar; 28(3):146-155. PubMed ID: 29331568 [Abstract] [Full Text] [Related]
2. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis. Simone G, Tuderti G, Anceschi U, Papalia R, Ferriero M, Misuraca L, Minisola F, Mastroianni R, Costantini M, Guaglianone S, Sentinelli S, Gallucci M. World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234 [Abstract] [Full Text] [Related]
3. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach. Badalato GM, Kates M, Wisnivesky JP, Choudhury AR, McKiernan JM. BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334 [Abstract] [Full Text] [Related]
4. Comparison of prognosis between patients undergoing radical nephrectomy versus partial nephrectomy for renal cell carcinoma ≤7 cm T3aN0/xM0: Survival benefit is biased toward partial nephrectomy. Liu S, Feng C, Liu C, Wang Z. Cancer Med; 2021 Dec; 10(24):8909-8923. PubMed ID: 34779154 [Abstract] [Full Text] [Related]
5. Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base. Ristau BT, Handorf EA, Cahn DB, Kutikov A, Uzzo RG, Smaldone MC. Cancer; 2018 Oct 01; 124(19):3839-3848. PubMed ID: 30207380 [Abstract] [Full Text] [Related]
6. Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis. O'Malley RL, Hayn MH, Brewer KA, Underwood W, Hellenthal NJ, Kim HL, Sorokin I, Schwaab T. World J Urol; 2015 Nov 01; 33(11):1807-14. PubMed ID: 25805189 [Abstract] [Full Text] [Related]
7. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. Mir MC, Derweesh I, Porpiglia F, Zargar H, Mottrie A, Autorino R. Eur Urol; 2017 Apr 01; 71(4):606-617. PubMed ID: 27614693 [Abstract] [Full Text] [Related]
8. Recurrence after radical and partial nephrectomy in high complex renal tumor using propensity score matched analysis. Kim H, Kim JK, Ye C, Choi JH, Lee H, Oh JJ, Lee S, Hong SK, Byun SS. Sci Rep; 2021 Feb 03; 11(1):2919. PubMed ID: 33536492 [Abstract] [Full Text] [Related]
9. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors. Kaushik D, Kim SP, Childs MA, Lohse CM, Costello BA, Cheville JC, Boorjian SA, Leibovich BC, Thompson RH. Eur Urol; 2013 Oct 03; 64(4):600-6. PubMed ID: 23280319 [Abstract] [Full Text] [Related]
10. Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma. Gershman B, Thompson RH, Boorjian SA, Lohse CM, Costello BA, Cheville JC, Leibovich BC. Eur Urol; 2018 Dec 03; 74(6):825-832. PubMed ID: 30262341 [Abstract] [Full Text] [Related]
11. A comparison of overall survival and perioperative outcomes between partial and radical nephrectomy for cT1b and cT2 renal cell carcinoma-Analysis of a national cancer registry. Venkatramani V, Koru-Sengul T, Miao F, Nahar B, Prakash NS, Swain S, Punnen S, Ritch C, Gonzalgo M, Parekh D. Urol Oncol; 2018 Mar 03; 36(3):90.e9-90.e14. PubMed ID: 29254672 [Abstract] [Full Text] [Related]
12. Is imperative partial nephrectomy feasible for kidney cancer with venous thrombus involvement? Outcomes of 42 cases and matched pair analysis with a large radical nephrectomy cohort. Marra G, Gontero P, Brattoli M, Filippini C, Capitanio U, Montorsi F, Daneshmand S, Huang WC, Linares Espinós E, Martínez-Salamanca JI, McKiernan JM, Zigeuner R, Libertino JA. Urol Oncol; 2018 Jul 03; 36(7):339.e1-339.e8. PubMed ID: 29801993 [Abstract] [Full Text] [Related]
13. Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy? Capitanio U, Stewart GD, Klatte T, Akdogan B, Roscigno M, Marszalek M, Dell'Oglio P, Zaffuto E, Rodriguez Faba O, Salagierski M, Lingard J, Carini M, Ouzaid I, Mir MC, Montorsi F, Da Pozzo LF, Stief C, Minervini A, Brookman-May SD. Eur Urol Focus; 2018 Dec 03; 4(6):972-977. PubMed ID: 28753867 [Abstract] [Full Text] [Related]
14. Survival advantage of partial over radical nephrectomy in patients presenting with localized renal cell carcinoma. Roos FC, Steffens S, Junker K, Janssen M, Becker F, Wegener G, Brenner W, Steinestel J, Schnoeller TJ, Schrader M, Hofmann R, Thüroff JW, Kuczyk MA, Wunderlich H, Siemer S, Hartmann A, Stöckle M, Schrader AJ, German Renal Cell Cancer Network. BMC Cancer; 2014 May 26; 14():372. PubMed ID: 24885955 [Abstract] [Full Text] [Related]
15. Robotic partial nephrectomy vs minimally invasive radical nephrectomy for clinical T2a renal mass: a propensity score-matched comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group. Bradshaw AW, Autorino R, Simone G, Yang B, Uzzo RG, Porpiglia F, Capitanio U, Porter J, Bertolo R, Minervini A, Lau C, Jacobsohn K, Ashrafi A, Eun D, Mottrie A, White WM, Schips L, Challacombe BJ, De Cobelli O, Mir CM, Veccia A, Larcher A, Kutikov A, Aron M, Dasgupta P, Montorsi F, Gill IS, Sundaram CP, Kaouk J, Derweesh IH. BJU Int; 2020 Jul 26; 126(1):114-123. PubMed ID: 32232920 [Abstract] [Full Text] [Related]
16. Percutaneous Ablation Versus Partial and Radical Nephrectomy for T1a Renal Cancer: A Population-Based Analysis. Talenfeld AD, Gennarelli RL, Elkin EB, Atoria CL, Durack JC, Huang WC, Kwan SW. Ann Intern Med; 2018 Jul 17; 169(2):69-77. PubMed ID: 29946703 [Abstract] [Full Text] [Related]
17. Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional Analysis. Patel SH, Uzzo RG, Larcher A, Peyronnet B, Lane BR, Pruthi D, Reddy M, Capitanio U, Joshi S, Noyes S, Eldefrawy A, Ghali F, Meagher MF, Hamilton ZA, Yim K, Nasseri R, Bradshaw AW, Dey S, Kirmiz S, Wan F, Liss MA, Bensalah K, Montorsi F, Derweesh IH. Clin Genitourin Cancer; 2020 Dec 17; 18(6):e723-e729. PubMed ID: 32600941 [Abstract] [Full Text] [Related]